Secondary breast cancer following hematologic malignancies. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a full text component.

Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study. Background: In the absence of curative treatment for the ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.

In semiconductor manufacturing, especially in electrical test data, but also in other parameters, there are often sets of parameters that are very highly correlated. Even a change in the correlation ...